Payer PolicyActive
CMM-207: Epidural Adhesiolysis
EVICORE-MSK_ADVANCED-D5FD8D7C
EviCore by Evernorth
Effective: May 31, 2023
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
EviCore classifies epidural adhesiolysis (catheter- or endoscopy-based; CPT 62263, 62264, 62280–62282) for treatment of back pain as experimental, investigational, or unproven and therefore not supported as a covered indication. No specific documentation requirements are specified; final reimbursement is determined by the individual’s health plan/benefit rules and atypical cases require physician review/consultation.
Coverage Criteria Preview
Key requirements from the full policy
"None — the document states that epidural adhesiolysis, performed by catheter or endoscopically, as a treatment for back pain is considered experimental, investigational, or unproven (EIU)."
Sign up to see full coverage criteria, indications, and limitations.